title: Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.
abstract: BACKGROUND
  Treatment of relapsed hematological malignancies after an allogeneic peripheral blood stem cell transplant (SCT) is challenging. Donor lymphocyte infusion (DLI) from the stem cell donor is an attractive clinical option to salvage this group of patients.
  
  
  METHODS
  We reviewed the important studies looking at donor lymphocyte infusion as a therapy for the treatment of hematological disorders that are either refractory to or have relapsed after allogeneic SCT.
  
  
  RESULTS
  The response to DLI is dependent upon type of disease, dose of infused lymphocytes, and the development of graft vs. host disease (GvHD). The best response rates are seen in patients with chronic myeloid leukemia (CML) followed by patients with lymphomas, multiple myeloma and acute leukemias, respectively. The responses in patients with CML are durable whereas durable responses in other diseases are rare.
  
  
  CONCLUSIONS
  Given the development of new drugs to treat some hematological diseases, DLI has taken a backseat. New modalities to target the infused cells to the tumor and new approaches to reduce GvHD that will augment the graft vs. leukemia/lymphoma (GvL) effect and decrease the injury to normal host tissues need to be developed. Understanding the factors and mechanisms that differentiate the GvL effect from GvHD will help in the development of newer treatment modalities.
authors.affiliation: Blood and Marrow Stem Cell Transplantation and Immunotherapy Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 4th Floor, Hudson Webber Cancer Research Center, 4100 John R., Detroit, MI 48201, USA.
authors.forename: Abhinav
authors.initials: A
authors.lastname: Deol
authors.forename: Lawrence G
authors.initials: LG
authors.lastname: Lum
mesh_terms: D006086:Graft vs Host Disease / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D017710:Lymphocyte Transfusion / Q000009:adverse effects; D008223:Lymphoma / Q000628:therapy*; D009101:Multiple Myeloma / Q000628:therapy*; D012008:Recurrence; D014019:Tissue Donors
references.citation: Bone Marrow Transplant. 1995 Jun;15(6):979-81
references.pmid: 7581101
references.citation: J Clin Oncol. 2000 Aug;18(16):3031-7
references.pmid: 10944138
references.citation: Blood. 1991 Oct 15;78(8):2120-30
references.pmid: 1912589
references.citation: Bone Marrow Transplant. 1998 Dec;22(11):1057-63
references.pmid: 9877267
references.citation: Blood. 1991 Feb 1;77(3):649-53
references.pmid: 1991174
references.citation: J Clin Oncol. 2007 Nov 1;25(31):4938-45
references.pmid: 17909197
references.citation: Leukemia. 2004 Nov;18(11):1789-97
references.pmid: 15385924
references.citation: Bone Marrow Transplant. 2004 Sep;34(6):511-4
references.pmid: 15273710
references.citation: Blood. 2000 Oct 15;96(8):2712-6
references.pmid: 11023502
references.citation: Ann Intern Med. 1988 Jun;108(6):806-14
references.pmid: 3285744
references.citation: Lancet. 1985 May 25;1(8439):1188-91
references.pmid: 2860389
references.citation: Lancet. 1978 Sep 9;2(8089):537-40
references.pmid: 79913
references.citation: Transplantation. 1990 Jul;50(1):175-7
references.pmid: 2368144
references.citation: Aust J Exp Biol Med Sci. 1975 Feb;53(1):27-42
references.pmid: 238498
references.citation: Biol Blood Marrow Transplant. 2001;7(1):31-8
references.pmid: 11215696
references.citation: Science. 1997 Jun 13;276(5319):1719-24
references.pmid: 9180086
references.citation: Ann Oncol. 2008 Nov;19(11):1935-40
references.pmid: 18684698
references.citation: Blood. 1997 May 1;89(9):3113-7
references.pmid: 9129013
references.citation: J Biol Response Mod. 1985 Dec;4(6):602-12
references.pmid: 3910764
references.citation: Bone Marrow Transplant. 1995 Sep;16(3):483-5
references.pmid: 8535325
references.citation: Biol Blood Marrow Transplant. 2008 Jan;14(1):50-8
references.pmid: 18158961
references.citation: J Clin Oncol. 2005 Aug 20;23(24):5675-87
references.pmid: 16110027
references.citation: Blood. 2000 Jan 1;95(1):67-71
references.pmid: 10607686
references.citation: Blood. 2002 Nov 1;100(9):3108-14
references.pmid: 12384406
references.citation: Blood. 1994 Aug 15;84(4):1050-5
references.pmid: 8049425
references.citation: Hum Gene Ther. 1998 Oct 10;9(15):2243-51
references.pmid: 9794208
references.citation: J Clin Oncol. 1997 Feb;15(2):433-44
references.pmid: 9053463
references.citation: J Clin Oncol. 1995 Jun;13(6):1312-22
references.pmid: 7751876
references.citation: Br J Haematol. 2005 Jan;128(2):153-68
references.pmid: 15638849
references.citation: Blood. 1996 Mar 15;87(6):2195-204
references.pmid: 8630379
references.citation: J Clin Oncol. 1993 Feb;11(2):304-13
references.pmid: 8426208
references.citation: Bone Marrow Transplant. 1995 Jul;16(1):43-55
references.pmid: 7581128
references.citation: Bone Marrow Transplant. 1986 Dec;1(2):133-40
references.pmid: 3332128
references.citation: Bone Marrow Transplant. 2000 Dec;26(11):1179-84
references.pmid: 11149728
references.citation: Blood. 1996 Apr 1;87(7):3053-60
references.pmid: 8639929
references.citation: Blood. 2007 Oct 1;110(7):2761-3
references.pmid: 17579184
references.citation: J Immunother. 2009 Feb-Mar;32(2):195-202
references.pmid: 19238019
references.citation: J Clin Immunol. 2002 Mar;22(2):64-9
references.pmid: 11998894
references.citation: Blood. 2001 Aug 15;98(4):934-9
references.pmid: 11493435
references.citation: Cancer Chemother Biol Response Modif. 2005;22:273-91
references.pmid: 16110617
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8639-44
references.pmid: 10411928
references.citation: Blood. 2002 Mar 15;99(6):1928-37
references.pmid: 11877262
references.citation: Bone Marrow Transplant. 2006 Jun;37(12):1135-41
references.pmid: 16757975
references.citation: Blood. 1997 Oct 1;90(7):2529-34
references.pmid: 9326217
references.citation: N Engl J Med. 1979 May 10;300(19):1068-73
references.pmid: 34792
references.citation: Blood. 1996 Dec 15;88(12):4711-8
references.pmid: 8977265
references.citation: Exp Hematol. 2005 Apr;33(4):452-9
references.pmid: 15781336
references.citation: Bone Marrow Transplant. 2005 Jul;36(2):163-9
references.pmid: 15937507
references.citation: Bone Marrow Transplant. 2000 Sep;26(5):511-6
references.pmid: 11019840
references.citation: Bone Marrow Transplant. 2003 Apr;31(8):725-6; author reply 727
references.pmid: 12822577
references.citation: Nat Rev Cancer. 2004 May;4(5):371-80
references.pmid: 15122208
references.citation: Blood. 2001 Mar 1;97(5):1249-57
references.pmid: 11222367
references.citation: Blood. 1996 Oct 1;88(7):2787-93
references.pmid: 8839877
references.citation: Br J Haematol. 1991 Dec;79(4):567-74
references.pmid: 1772778
references.citation: Blood. 2008 Dec 1;112(12):4371-83
references.pmid: 19029455
references.citation: Bone Marrow Transplant. 1994 Aug;14(2):331-2
references.pmid: 7994252
references.citation: Blood. 1999 Nov 1;94(9):3135-40
references.pmid: 10556200
references.citation: Blood. 1997 Nov 15;90(10):4206-11
references.pmid: 9354693
references.citation: Hum Immunol. 2003 Jan;64(1):56-68
references.pmid: 12507815
references.citation: J Clin Oncol. 1989 Jan;7(1):50-7
references.pmid: 2642540
references.citation: Bone Marrow Transplant. 2009 Mar;43(5):383-97
references.pmid: 18850012
references.citation: J Clin Oncol. 2003 Oct 15;21(20):3744-53
references.pmid: 12963703
references.citation: Blood. 1993 Oct 15;82(8):2310-8
references.pmid: 8400284
references.citation: Leukemia. 1997 Apr;11 Suppl 3:512-5
references.pmid: 9209441
references.citation: Cancer Res. 1999 Apr 1;59(7):1525-30
references.pmid: 10197624
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3675-84
references.pmid: 11504749
references.citation: Bone Marrow Transplant. 1992 Oct;10(4):391-5
references.pmid: 1422499
references.citation: Exp Hematol. 1995 Dec;23(14):1574-80
references.pmid: 8542949
references.citation: Blood. 2001 May 1;97(9):2574-9
references.pmid: 11313244
references.citation: Transplantation. 1983 Oct;36(4):369-72
references.pmid: 6353702
references.citation: Blood. 1995 Sep 1;86(5):2041-50
references.pmid: 7655033
references.citation: Leukemia. 2001 Sep;15(9):1339-46
references.pmid: 11516094
references.citation: N Engl J Med. 2003 Mar 13;348(11):994-1004
references.pmid: 12637609
references.citation: Br J Haematol. 1988 Jun;69(2):239-45
references.pmid: 3291930
references.citation: Blood. 2002 May 15;99(10):3530-9
references.pmid: 11986204
references.citation: Br J Haematol. 1988 Nov;70(3):317-20
references.pmid: 3061443
references.citation: Br J Haematol. 1986 Jun;63(2):221-30
references.pmid: 3521712
references.citation: Prog Clin Biol Res. 1985;193:315-25
references.pmid: 3911215
references.citation: Blood. 2004 Dec 15;104(13):3865-71
references.pmid: 15304395
references.citation: J Hematother. 1992 Spring;1(1):85-94
references.pmid: 1365020
references.citation: Bone Marrow Transplant. 1992 Sep;10(3):301-4
references.pmid: 1422483
references.citation: Blood. 1992 Mar 1;79(5):1379-81
references.pmid: 1536963
references.citation: Blood. 2000 Feb 15;95(4):1214-21
references.pmid: 10666193
references.citation: Blood. 1990 Dec 15;76(12):2462-5
references.pmid: 2265242
references.citation: Lancet. 1995 Apr 22;345(8956):1016-20
references.pmid: 7723498
references.citation: Leukemia. 1996 Jul;10(7):1168-76
references.pmid: 8683998
references.citation: Bone Marrow Transplant. 1997 Apr;19(7):709-19
references.pmid: 9156249
references.citation: Blood. 2004 Feb 15;103(4):1548-56
references.pmid: 14576063
references.citation: Ann Intern Med. 1992 Mar 15;116(6):505-12
references.pmid: 1739242
references.citation: Bone Marrow Transplant. 1986 May;1(1):53-66
references.pmid: 3332120
references.citation: J Clin Oncol. 1993 Mar;11(3):513-9
references.pmid: 8445426
references.citation: Bone Marrow Transplant. 1993 Oct;12(4):405-7
references.pmid: 8275041
references.citation: Transplantation. 1984 Feb;37(2):151-5
references.pmid: 6364497
references.citation: N Engl J Med. 1981 Jun 18;304(25):1529-33
references.pmid: 7015133
references.citation: Br J Haematol. 2007 Oct;139(1):70-80
references.pmid: 17854309
references.citation: Bone Marrow Transplant. 2007 Aug;40(4):355-9
references.pmid: 17563732
references.citation: Immunity. 1996 Aug;5(2):115-24
references.pmid: 8769475
references.citation: Bone Marrow Transplant. 1992 Apr;9(4):269-75
references.pmid: 1600415
references.citation: Blood. 1990 Feb 1;75(3):555-62
references.pmid: 2297567
references.citation: J Clin Oncol. 1987 Mar;5(3):376-81
references.pmid: 3546614
references.citation: Blood. 1996 Jul 1;88(1):41-8
references.pmid: 8704200
references.citation: Bone Marrow Transplant. 1999 Jan;23(2):195-7
references.pmid: 10197809
references.citation: Transplantation. 1994 Jan;57(1):82-7
references.pmid: 8291119
references.citation: Proc Natl Acad Sci U S A. 1982 Oct;79(19):6047-51
references.pmid: 6764536
references.citation: Hum Immunol. 2002 Mar;63(3):200-10
references.pmid: 11872238
references.citation: Nat Med. 1996 Jan;2(1):52-8
references.pmid: 8564842
references.citation: J Exp Med. 1999 Jan 18;189(2):301-8
references.pmid: 9892612
references.citation: N Engl J Med. 1957 Sep 12;257(11):491-6
references.pmid: 13464965
references.citation: Bone Marrow Transplant. 2000 Oct;26(7):769-74
references.pmid: 11042659
references.citation: Bone Marrow Transplant. 2003 Dec;32(12):1159-63
references.pmid: 14647270